23 October 2014
The Chancellor of the Exchequer, George Osborne, has today announced that a partnership led by the MRC will invest over £230 million in a range of revolutionary technologies aimed at identifying the causes of diseases such as cancer and dementia.
13 October 2014
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
7 October 2014
Three ambitious new research programmes, which aim to deliver a step-change in our understanding of disease by using human volunteers in experimental studies, have been funded as part of a £60m investment from the Medical Research Council (MRC).